Facial rejuvenation is often described as a combination of lifting, volume restoration and skin treatment. The more important question is sequence: which problem should be addressed first, which procedures can be combined, and when is staging safer or more precise?
Start by separating three different problems
- Position: descent of the brow, midface, jawline or neck tissues.
- Volume: deflation or skeletal support that affects proportion and contour.
- Skin quality: pigment, fine lines, texture, vascular change and sun damage.
These problems can coexist, but they are not interchangeable. Filler cannot reliably lift descended tissues, and a facelift does not erase pigment or every fine line.
When position usually comes first
If tissue descent is the dominant issue, structural repositioning may need to precede—or be coordinated with—volume and skin treatments. Depending on the region, options can include video-assisted brow or midface surgery, blepharoplasty, a SMAS-based or Deep Plane facelift, Neck Lift or selective Deep Neck surgery.
The chosen technique depends on the anatomy and the regions that need treatment. Deep Plane is not automatically the best or most complete approach, and video-assisted surgery does not replace treatment of the lower face or neck.
Read how the scope of facelift surgery is matched to facial regions.
Volume: add only where it serves the face
Microfat can restore selected structural volume, while nanofat is a finely processed preparation used for more superficial indications and does not function as a lifting material. Fat retention varies, and excessive or poorly placed volume can obscure facial contours.
For some patients, limited fat grafting can be performed during surgery. For others, waiting until swelling settles makes the remaining volume deficit easier to judge. Weight should be reasonably stable because transferred fat responds to later weight change.
Previous injectables may change the sequence
Fillers, biostimulators, threads, PMMA, silicone and energy-based treatments can alter tissue planes, create inflammation or complicate interpretation of facial volume. The patient should provide product names, dates and treated areas. Dermatologic ultrasound may be recommended when examination cannot define what is present.
Hyaluronidase can dissolve hyaluronic-acid filler, but it does not remove PMMA, silicone, most biostimulators or fat. Treatment of inflammation or product-related edema may need to occur before surgery. See planning a facelift after injectables.
Skin treatments are often staged
Peels, lasers, energy devices and other dermatologic treatments have their own healing demands. Combining them with facial surgery may increase inflammation or skin risk in some patients. When performed later, they can be selected according to the skin changes that remain after structural recovery.
The appropriate interval is individualized. After larger facial operations, treatments are commonly deferred until incisions and circulation are stable and swelling has substantially improved.
Combined surgery versus staged treatment
Combining procedures can reduce the number of anesthetics and create regional balance. It can also lengthen surgery, increase swelling and make recovery more demanding. Staging may be preferable when:
- the total operative scope would be excessive;
- eye-surface health or other medical conditions require caution;
- prior injectables or inflammation need investigation;
- weight is changing, including during GLP-1 treatment;
- the priority is uncertain or the patient needs time to decide.
A sequence built around safety and identity
The aim is not to perform every available procedure. It is to treat the dominant anatomical problem first, preserve expression and recognizable facial identity, and use later steps only when they add a clear benefit. International patients should also allow enough time near the team; major facial surgery generally requires at least 15 days in Brazil before travel is considered. Review the international preparation checklist and concierge support.
